{"drugs":["Ciclodan","Ciclopirox Olamine","Loprox"],"mono":{"0":{"id":"123978-s-0","title":"Generic Names","mono":"Ciclopirox Olamine"},"1":{"id":"123978-s-1","title":"Dosing and Indications","sub":{"0":{"id":"123978-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Candidiasis of skin, Due to Candida albicans:<\/b> TOPICAL, massage cream, lotion, or suspension into affected skin twice daily<\/li><li><b>Tinea, Tinea pedis, tinea cruris, tinea corporis, tinea versicolor:<\/b> TOPICAL, massage cream, lotion, or suspension into affected skin twice daily<\/li><\/ul>"},"1":{"id":"123978-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>safety and efficacy not demonstrated in children less than 10 years old<\/li><li><b>Candidiasis of skin, Due to Candida albicans:<\/b> TOPICAL (10 y and older) massage cream, lotion, or suspension into affected skin twice daily<\/li><li><b>Tinea, Tinea pedis, tinea cruris, tinea corporis, tinea versicolor:<\/b> TOPICAL (10 y and older) massage cream, lotion, or suspension into affected skin twice daily<\/li><\/ul>"},"3":{"id":"123978-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Candidiasis of skin, Due to Candida albicans<\/li><li>Tinea, Tinea pedis, tinea cruris, tinea corporis, tinea versicolor<\/li><\/ul>"}}},"3":{"id":"123978-s-3","title":"Contraindications\/Warnings","sub":[{"id":"123978-s-3-9","title":"Contraindications","mono":"hypersensitivity to ciclopirox olamine products<br\/>"},{"id":"123978-s-3-10","title":"Precautions","mono":"age less than 10 yr<br\/>"},{"id":"123978-s-3-11","title":"Pregnancy Category","mono":"<ul><li>Ciclopirox: B (FDA)<\/li><li>Ciclopirox: B3 (AUS)<\/li><\/ul>"},{"id":"123978-s-3-12","title":"Breast Feeding","mono":"Ciclopirox: Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"123978-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Dermatologic:<\/b>Burning sensation, Pruritus<br\/>"},"6":{"id":"123978-s-6","title":"Drug Name Info","sub":{"0":{"id":"123978-s-6-17","title":"US Trade Names","mono":"<ul><li>Loprox<\/li><li>Ciclodan<\/li><\/ul>"},"2":{"id":"123978-s-6-19","title":"Class","mono":"Antifungal<br\/>"},"3":{"id":"123978-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"123978-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"123978-s-7","title":"Mechanism Of Action","mono":"Ciclopirox olamine, a fungicidal agent, inhibits the growth of a wide variety of pathogenic fungi.<br\/>"},"8":{"id":"123978-s-8","title":"Pharmacokinetics","sub":{"0":{"id":"123978-s-8-23","title":"Absorption","mono":"Bioavailability: (with polyethylene glycol 400) 1.3% <br\/>"},"3":{"id":"123978-s-8-26","title":"Excretion","mono":"<ul><li>Fecal: negligible<\/li><li>Renal: 0.01%<\/li><\/ul>"},"4":{"id":"123978-s-8-27","title":"Elimination Half Life","mono":"1.7 h <br\/>"}}},"9":{"id":"123978-s-9","title":"Administration","mono":"<b>Topical<\/b><br\/><ul><li>gently massage cream or lotion into affected areas and surrounding skin twice a day (morning and evening)<\/li><li>avoid use of occlusive dressing<\/li><\/ul>"},"10":{"id":"123978-s-10","title":"Monitoring","mono":"<ul><li>resolution or improvement of clinical signs and symptoms<\/li><li>increased irritation, erythema, itching, burning, blistering, swelling, or oozing at application site<\/li><li>no improvement in or worsening of symptoms<\/li><\/ul>"},"11":{"id":"123978-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/>Topical Cream: 0.77 %<br\/><\/li><li><b>Ciclodan<\/b><br\/>Topical Cream: 0.77 %<br\/><\/li><li><b>Loprox<\/b><br\/>Topical Cream: 1 %<br\/><\/li><\/ul>"},"13":{"id":"123978-s-13","title":"Clinical Teaching","mono":"<ul><li>Advise patients to report increased irritation, erythema, itching, burning, blistering, swelling, or oozing at application site.<\/li><li>Instruct patients to avoid use of occlusive dressings.<\/li><li>Patient should not use nail polish or false-nails if using drug to treat fingernails or toenails.<\/li><\/ul>"}}}